{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:53:42Z","timestamp":1787136822629,"version":"build-2736575974"},"reference-count":28,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The authors previously confirmed the serum uric acid-lowering effects of the combination of glycine and tryptophan in subjects with mild hyperuricemia. This study examined whether combined supplementation with glycine and tryptophan suppressed the elevation in serum uric acid levels caused by purine ingestion and accelerated urinary uric acid excretion in subjects with lower urate excretion using a randomized, single-blind, placebo-controlled, crossover clinical trial design. Healthy Japanese adult males with lower urate excretion ingested water containing purines in addition to dextrin (placebo), tryptophan, glycine, or a glycine and tryptophan mixture. The combined supplementation with glycine and tryptophan significantly reduced the elevated serum uric acid levels after purine ingestion. Glycine alone and in combination with tryptophan significantly increased urinary uric acid excretion and urate clearance compared with the effects of the placebo. Urinary pH increased by the ingestion of the mixture. These results suggested that the improved water solubility of uric acid due to increased urinary pH contributed to the increase of urinary uric acid excretion.<\/jats:p>","DOI":"10.3390\/nu11112562","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T03:20:36Z","timestamp":1571973636000},"page":"2562","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Combined Supplementation with Glycine and Tryptophan Reduces Purine-Induced Serum Uric Acid Elevation by Accelerating Urinary Uric Acid Excretion: A Randomized, Single-Blind, Placebo-Controlled, Crossover Study"],"prefix":"10.3390","volume":"11","author":[{"given":"Shunji","family":"Oshima","sequence":"first","affiliation":[{"name":"Core Technology Laboratories, Asahi Quality &amp; Innovations, Ltd., 1-21, Midori 1-Chome, Moriya-Shi 302-0106, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachie","family":"Shiiya","sequence":"additional","affiliation":[{"name":"Core Technology Laboratories, Asahi Quality &amp; Innovations, Ltd., 1-21, Midori 1-Chome, Moriya-Shi 302-0106, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Core Technology Laboratories, Asahi Quality &amp; Innovations, Ltd., 1-21, Midori 1-Chome, Moriya-Shi 302-0106, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.semarthrit.2016.08.006","article-title":"The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012","volume":"46","author":"Rai","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: A nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","article-title":"National prevalence of gout derived from administrative health data in Aotearoa New Zealand","volume":"51","author":"Winnard","year":"2012","journal-title":"Rheumatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/rheumatology\/kem150","article-title":"Is gout associated with reduced quality of life? A case-control study","volume":"46","author":"Roddy","year":"2007","journal-title":"Rheumatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","article-title":"Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans","volume":"67","author":"Singh","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/rheumatology\/kep047","article-title":"Perceptions of disease and health-related quality of life among patients with gout","volume":"48","author":"Lee","year":"2009","journal-title":"Rheumatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/15257770.2011.596496","article-title":"Japanese guideline for the management of hyperuricemia and gout: Second edition","volume":"30","author":"Yamanaka","year":"2011","journal-title":"Nucleos. Nucleot. Nucl."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1185\/03007995.2010.533647","article-title":"Chronic gout: Epidemiology, disease progression, treatment and disease burden","volume":"26","author":"Brook","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1517\/17460441.2.9.1251","article-title":"Drug discovery for hyperuricemia","volume":"2","author":"Anzai","year":"2007","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0021-9258(20)70832-X","article-title":"Purine metabolism. II. The effect of the ingestion of glycine on the excretion of endogenous uric acid","volume":"83","author":"Christman","year":"1929","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI101864","article-title":"The effect of glycine on the production and excretion of uric acid","volume":"26","author":"Friedman","year":"1947","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/ard.10.3.353","article-title":"Gout: Observations on the effects of drugs on plasma uric acid and urinary uric acid","volume":"10","author":"Kersley","year":"1951","journal-title":"Ann. Rheum. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Oshima, S., Shiiya, S., and Nakamura, Y. (2019). Serum Uric acid-lowering effects of combined glycine and tryptophan treatments in subjects with mild hyperuricemia: A randomized, double-blind, placebo-controlled, crossover study. Nutrients, 11.","DOI":"10.3390\/nu11030564"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7143\/jhep.39.313","article-title":"Characteristics of the guideline for the management of hyperuricemia and gout, 2nd edition","volume":"39","author":"Shio","year":"2012","journal-title":"Health Eval. Promot."},{"key":"ref_16","first-page":"863","article-title":"Clinical calorimetry: Tenth paper a formula to estimate the approximate surface area if height and weight be known","volume":"17","year":"1916","journal-title":"Arch. Intern. Med."},{"key":"ref_17","first-page":"998","article-title":"Validation of an analytical method for human plasma free amino acids by high-performance liquid chromatography ionization mass spectrometry using automated precolumn derivatization","volume":"15","author":"Yoshida","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_18","first-page":"15","article-title":"Beneficial effects of the amino acid glycine","volume":"17","year":"2017","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3945\/jn.112.173823","article-title":"Supplementing healthy women with up to 5.0 g\/d of L-tryptophan has no adverse effects","volume":"143","author":"Hiratsuka","year":"2013","journal-title":"J. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF02474201","article-title":"Solubility of uric acid and monosodium urate","volume":"10","author":"Wilcox","year":"1972","journal-title":"Med. Biol. Eng."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2891-11-39","article-title":"Effect of urine pH changed by dietary intervention on uric acid clearance mechanism of pH-dependent excretion of urinary uric acid","volume":"11","author":"Kanbara","year":"2012","journal-title":"Nutr. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-5347(17)46962-X","article-title":"Long-term treatment of calcium nephrolithiasis with potassium citrate","volume":"134","author":"Pak","year":"1985","journal-title":"J. Urol."},{"key":"ref_23","first-page":"342","article-title":"Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate\/uric acid) renal stones","volume":"48","author":"Alvarez","year":"1992","journal-title":"Urol. Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ki.1983.165","article-title":"Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts","volume":"24","author":"Sakhaee","year":"1983","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.ASN.0000105320.04395.D0","article-title":"Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion","volume":"15","author":"Ichida","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9343(70)80027-4","article-title":"Effect of glycine loading on plasma and urinary uric acid and amino acids in normal and gouty subjects","volume":"49","author":"Kaung","year":"1970","journal-title":"Am. J. Med."},{"key":"ref_27","first-page":"F61","article-title":"Indirect coupling of urate and p-aminohippurate transport to sodium in human brush-border membrane vesicles","volume":"270","author":"Guisan","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2527\/1991.6941532x","article-title":"Protein and energy requirements of animals treated with \u03b2-adrenergic agonists: A discussion","volume":"69","author":"Reeds","year":"1991","journal-title":"J. Anim. Sci."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/11\/11\/2562\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:28:50Z","timestamp":1760189330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/11\/11\/2562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["nu11112562"],"URL":"https:\/\/doi.org\/10.3390\/nu11112562","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]}}}